The Royal Veterinary College has raised £45 million to invest in campus developments supporting education, research and veterinary services.

The finance was raised via a private placement with Sun Life Investment Management.

The College says it chose to finance via the private placement market due to the supportive buy and hold nature of the investor base, the strong demand within it for high quality higher education credits and the negotiated nature of the market. 

In the top three of the QS world university rankings and with a strong financial performance history, the RVC’s £45 million senior unsecured note offering generated significant investor interest both within the UK and North America; with the offer four times over-subscribed, the RVC was able to take advantage of highly competitive long-term interest rates.

The secured funding will allow capital developments on both of the College's campuses.

Professor Stuart Reid, the RVC Principal, said: "I am absolutely delighted that we have secured this innovative blue chip financial backing in a deal which reflects our international reputation and leadership in the veterinary and biomedical sciences. We now look forward to investing in the next phase of capital development at the RVC, securing our position for years to come."

Candace Shaw, Head of Private Fixed Income, Sun Life Investment Management, said: "We are pleased to support the continued growth of the RVC, a specialised higher education institution with a renowned reputation both in the UK and internationally.  The financing of the RVC represents a sound investment and aligns to Sun Life’s long-term investment objectives in this sector."

Pets at Home has recalled four dry cat food products marketed under the AVA brand after three cats became seriously ill, four to six weeks after switching to the products.

Further investigation revealed that the products in question: AVA Mature Cat Chicken 2kg, AVA Mature Cat Chicken 4kg, AVA Senior Cat Chicken 2kg and AVA Adult Cat Neutered Indoor 1.5kg, all had insufficient levels of thiamine (vitamin B1), which caused the cats to exhibit symptoms of sudden collapse, fitting, widespread twitching and general unsteadiness.

Talking to the BBC, Pets at Home spokesperson Brian Hudspith said it was important to alert veterinary surgeons as well as customers because thiamine deficient cats would usually present with quite different symptoms, including stiff limbs and the head falling onto the sternum.

He said: "Rather than the more typical cervical ventroflexion (head falling onto the chest) associated with thiamine deficiency, in the three cases we saw the predominant clinical signs included sudden collapse, fitting, widespread twitching and general unsteadiness on their legs, which began suddenly after 4-6 weeks of being on the diet."

Pet owners who have bought the products are being advised by the company to dispose of the contents and return the packaging to any Pets at Home store for a full refund. Owners who think their cat is demonstrating any of the symptoms are being advised to seek immediate veterinary advice, and to contact the company's customer advisors on 0800 328 4204.

IMPORTANT UPDATE
Davies Veterinary Specialists has published advice and support for veterinary professionals and pet owners concerning the diagnosis and treatment of thiamine deficiency in cats, here.

Royal Canin has announced the launch of its Christmas promotion through which practice clients will be rewarded with activity balls for cats and leashpods for dogs.

The stocking fillers will be distributed to practices along with promotional materials such as posters and shelf wobblers, to encourage clients to buy Royal Canin Veterinary Care Nutrition (VCN) pet food.

Veterinary Marketing Manager, Lindsay Calcraft, said: "Customers who purchase any 1.5kg bag of feline VCN or any 3.5kg bag of canine VCN from their vet will receive a cat activity ball or a leashpod to thank them for their custom and support.

"For those who don't know what a leashpod is, it's a fantastic dog lead handle to help you carry all those essential items needed for walking a dog. It has an integrated bag dispenser, its own scented mini bin for storing smelly used bags and two secure pockets for treats, keys, money or your mobile phone."

For more information about the Christmas promotion, visit www.royalcanin.co.uk or contact your Veterinary Business Manager.

Improve International has launched a Distance Learning Postgraduate Certificate in Exotic Animal Practice.

The programme, which starts in July, will cover a range of different exotic species, from initial examination and diagnostic sample collection to anaesthesia, surgery, and diagnostic imaging. It will also cover the workup and treatment of common diseases seen in these species. 

Delegates can opt to attend three practical attendance modules which will cover small mammal surgery, avian surgery and endoscopy.

Course Director Simon Girling BVMS (Hons) DZooMed, DipECZM (ZHM), CBiol, FRSB, EurProBiol, FRCVS RCVS Recognised Specialist in Zoo and Wildlife Medicines, said: “Exotic Animal medicine is a rapidly changing discipline with new information and a greater understanding of individual species' needs growing with each passing day. The programme aims to give the delegate an in-depth view of the current best practice in exotic animal medicine and surgery and is directly relevant to the day-to-day work of the veterinary surgeon in clinical practice.

“Our expert Module Tutors, including Charly Pignon DVM Dipl. ECZM, Richard A Saunders BSc (Hons) BVSc FRSB CBiol DZooMed (Mammalian) DipECZM (ZHM) MRCVS RCVS Specialist in Zoo and Wildlife Medicine (Mammalian) European Specialist in Zoological Medicine (ZHM) and Stephen Divers BVetMed, DZooMed, DECZM(Herp) DECZM(ZHM) DACZM FRCVS, will provide support during every module.”

David Babington MRCVS, Business Development Director at Improve International, added: “We know that the prospect of treating exotic patients can fill veterinary surgeons with dread.  Taking this course will increase their confidence by building their knowledge of the fundamentals of exotic animal medicine and surgery.  In doing so, they will also be able to take more informed clinical approach to treating these patients.”

The programme offers a route to achieve academic qualifications - the General Practitioner Certificate (GPCert) and the Postgraduate Certificate (PgC), in partnership with ISVPS and Harper Adams University. Gaining a PgC enables delegates to apply to the RCVS for Advanced Practitioner Status in the subject.

For further information and to register interest visit: https://www.improveinternational.com/uk/course/exotic-animal-practice-distance-learning/

You can also watch a video in which Simon Girling introduces the course: https://www.youtube.com/watch?v=6NoRy4ZK5Dw

The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.

In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.

The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.

The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.

In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.

Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.

Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.

Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee. 

"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."

Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.

To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).

"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.

"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."

Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.

CVS has announced its acquisition of the West End Veterinary Partnership, an Edinburgh-based veterinary practice, bringing the number of practice groups owned by the company to 100, operating out of 267 sites across the UK.

West End Vets employs around 12 staff. Its main site is in Bread Street and it has two branches elsewhere in the city. Owners David Rimer and Maurice Hunter are joining CVS as joint Clinical Directors.

Simon Innes, CVS Chief Executive, said:  "We are rapidly broadening the range of practices within CVS, both in terms of the type of practice and in terms of geographic spread. West End Vets is a successful and popular practice in Edinburgh and we are delighted that it has now joined our family."

Founded in 1999 and run principally by vets, CVS employs more than 3,000 staff at its practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, three pet crematoriums and five veterinary laboratories.

Bristol-based Invatech Health has joined forces with MWI to establish a new distribution service whereby prescriptions are sent directly to the client from the wholesaler. 

The new distribution service uses Invatech's Patient Medication Record (PMR) system, called Titan, which was accredited by the NHS a little over a year ago. Titan has now been developed further to support the company's Home Pharmacy service, and integrate with MWI.

The company says the new system offers practices a seamless workflow between prescribing, dispensing and logistics systems.

Tariq Muhammad, CEO of Invatech Health, said: "“The use of PMR systems for the veterinary market has been very light touch until now. Knowing that that we can bring the same level of efficiency and workflow to a new market presents an opportunity to support animal health in the same way that we do for human health."

Alan White, Commercial Director at MWI Animal Health, said: “The Covid pandemic has presented many challenges to veterinary professionals in the UK. Travel restrictions and social distancing measures make it difficult for animal owners to collect the medications and treatments they need from veterinary practices.”

“We are excited to be able to work with Invatech to provide an innovative solution to this problem, where vets can send the medications needed directly to their client. Working in partnership with veterinary practices and Invatech means we can move animal health forward together.”

For more information, visit: https://www.invatechhealth.com/ 

Virbac Animal Health is offering practices an educational shampoo and skin care pack for pet owners. 

The pack is free to practices that buy any 12 shampoos from the Virbac range. In return the practice will receive a range of educational and point of sale materials, including a counter display unit and 'give away' hand sanitisers. Each practice also receives 2 free shampoos and a bottle of either Humilac or Dermacool FOC.

According to the company, the idea behind the initiative is to help pet owners understand the importance of bathing their pets, and of correct product selection.

Product manager Chris Geddes MRCVS said: "We also hope that it will assist vets and VNs to easily identify the correct product for every type of skin. 

"The colour-coordinated packaging and literature contains easy-to-follow advice for pet owners and vet staff. And with all the extra items, we believe the promotion is great value for money."

Chris also believes the pack will help pet owners to understand the importance of regular and correct bathing: "Many owners just accept that their pet smells, without realising that this shouldn't be the case. This is the 'doggy' smell that many owners accept as normal."

"Also, many owners who do bathe their pets use soaps or shampoos from their own bathroom, not knowing that these are totally unsuitable for animals. Hopefully this promotion will help pet owners understand why it is important to use specifically formulated products for their pet."

The promotion runs until the end of July. Those interested in the pack please contact your Virbac territory manager or call the company on 01359 243243.

The British Veterinary Association is inviting vets to enter its third ‘BVA Veterinary photographer of the year’ competition.

Last year’s competition saw photographs span a range of subjects from across the UK and overseas, from a common basilisk in Costa Rica and cattle during a TB testing day on the island of Arran, to a meerkat undergoing a vasectomy and a veterinary podiatrist at work.

Small animal vet Mandy Knight’s photo 'Happy Gastrotomy' and mixed-practice vet Jen Rowland’s photo of rare and native North Ronaldsay and Dartmoor sheep grazing under the milky way in Northumberland took the top prizes in their respective categories.

In January this year, the BVA was also invited to showcase 22 of the most commended photographs at an exhibition in the Houses of Parliament, to give MPs and Peers an insight into the varied roles performed by veterinary surgeons today.

This year’s competition, which is open to all BVA members, seeks images that highlight the human-animal bond within a veterinary practice as well as photographs of pets or wildlife taken outside of the working environment. Submissions should promote responsible animal interaction as well positive animal health and welfare.

Photographs can be submitted under one of two categories: 

• Human-animal bond

• All creatures great and small

An expert panel of judges from the veterinary and photography worlds will judge this year’s entries. For the first time, BVA members will get the chance to select their favourite entry for the Members’ Choice Award, which will be open to votes from 27 August to 10 September.

The winner in each category will receive a £250 John Lewis gift voucher and have their photographs displayed at BVA Members’ Day in September, at other BVA events and used in BVA communications.

BVA President John Fishwick said: "The photo competition has created quite a buzz within the veterinary community since it launched two years ago. I have been delighted and amazed by the sheer range, quantity and quality of photographs submitted by our members so far and look forward to this year’s submissions.

"We are all passionate about animal health and welfare, so the way we interact with and capture images of the animal world offers a unique perspective, one that we were proud to showcase to members of parliament earlier this year. Whether you enjoy taking photos on your phone or have all the latest photography equipment, I would encourage all my colleagues within the veterinary family to give it a go and get clicking."

The competition closes at midnight on 19 August. More details about the competition, including terms and conditions, can be found at the BVA Photo Competition page: https://www.bva.co.uk/news-campaigns-and-policy/bva-photo-competition/

The full gallery of BVA Veterinary photographer of the year competition entries from 2016 and 2017 can be seen at: https://www.flickr.com/photos/britishvets/albums/

Photo: 'Happy Enterotomy' © Mandy Knight. CC BY-SA 2.0.

A study published in the Veterinary Record has shown that Plerion, the broad-spectrum anthelmintic combination preparation for dogs (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious and well-tolerated treatment against all important endoparasites, according to manufacturers Intervet Schering-Plough Animal Health. 

In addition, because Plerion is formulated as a flavored chewable tablet, the product was readily consumed by the vast majority of dogs.

Although the product has been on the market in the UK since last year, this is the first time that the evidence for its efficacy has been published in the public domain.

Linda Horspool BVMS, PhD, DipECVPT, MRCVS, Global Technical Director Companion Animal Pharmaceuticals at Intervet/Schering-Plough Animal Health said: "Pyrantel, oxantel and praziquantel, the active ingredients of Plerion, are well-established anthelmintics, having been used successfully in humans and animals for decades. The combination of these ingredients in one preparation offers the possibility to eliminate relevant parasites from most dogs in a single treatment. Moreover, the good palatability of the flavored chewable tablets makes Plerion easy to give and helps owners to remember to treat their dogs regularly which contributes to adequate deworming".

The efficacy, safety and palatability of a single-dose treatment with Plerion were assessed after experimental as well as natural infection with common helminths such as whipworms, tapeworms and roundworms. In five controlled studies (48 treated dogs/49 untreated dogs) and three field studies (30 treated dogs), a total of 127 animals were included. In all comparisons, Plerion-treated dogs had statistically significantly lower worm counts than untreated dogs. Moreover, in treated dogs efficacy against whipworms (Trichuris vulpis) was more than 99 percent after experimental infection and 100 percent after natural infection. For roundworms (Toxocara canis), the corresponding figures were 94 and 100 percent, respectively. For tapeworms (Echinococcus granulosus), the efficacy was more than 99 percent after experimental infection.

The preparation was well-tolerated, evidenced by the finding that treatment of dogs with doses up to 6 times the recommended dose or twice the recommended dose on 3 consecutive days did not result in adverse changes in blood parameters, clinical findings or behavior.

In client-owned dogs, Plerion was readily consumed as demonstrated by the fact that 88 percent of dogs spontaneously accepted the tablet. The proportion of spontaneous acceptance appeared higher than the 78 percent that was obtained with another commercially available flavored reference preparation containing pyrantel, febantel and praziquantel.

Worm infestations in dogs are important parasites in terms of prevalence, pathogenicity and, occasionally, zoonotic impact. Therefore, the European Scientific Counsel on Companion Animal Parasites (ESCCAP) has re-emphasized in its 2010 guideline update titled "Worm Control in Dogs and Cats" that veterinarians and pet owners (1) must take measures to protect pets from parasitic infestations, (2) protect the pet population from risks associated with travel and its consequent potential to change local parasite epidemiological situations through the export or import of non-endemic parasite species, and (3) should work together to reduce the risks associated with zoonotic transmission of parasitic diseases.

*Reference
Schmid K, Rohdich N, Zschiesche E, Kok DJ, Allan MJ. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs. Veterinary Record 2010;167:647-651

The RSPB has reported the results of two studies which revealed that a greater diversity of birds of prey, including some eagles, are killed eating carrion contaminated with diclofenac.

The RSPB says that these findings strengthen the case of banning the use of veterinary diclofenac in livestock across Europe, including Spain and Italy where the drug has already been approved.

In the first paper¹, published in the journal Bird Conservation International, scientists present results of tests carried out on two steppe eagles found dead at a cattle carcass dump in Rajasthan, India. Both birds had diclofenac residue in their tissues and exhibited the same clinical signs of kidney failure as seen in Gyps vultures experimentally given diclofenac. 

Steppe eagles are closely related to the golden eagles found in the UK, the vulnerable Spanish imperial eagle and other globally vulnerable or declining Eurasian eagles. Scientists now fear that all species in this genus, known as Aquila, are susceptible to diclofenac. With fourteen species of Aquila eagle distributed across Asia, Africa, Australia, Europe and North America, this means that diclofenac poisoning should now be considered largely a global problem.

Dr Toby Galligan, RSPB conservation scientist and one of the authors of the paper, said: "We have known for some time that diclofenac is toxic to Gyps vultures, including the Eurasian griffon vulture, but we now know it is toxic to an Aquila eagle too. This suggests that the drug is fatal to a greater number of birds of prey in Asia, Europe and around the world. We had suspected as much from observed declines in non-Gyps vultures in Asia, but this study confirms our worst fears."

In another paper², published in Bird Conservation International, Dr Galligan led an examination of recent population trends in Egyptian and red-headed vultures in India. That study shows population declines of similar timing and scale as the declines observed in Gyps vultures, providing indirect evidence that these species have been impacted by diclofenac as well. 

After years of campaigning by conservationists, the governments of Bangladesh, India, Nepal, and Pakistan banned veterinary formulations of diclofenac between 2006 and 2010. Recently, experts have recorded a slowing of Gyps vulture declines as a result of the bans. However, formulations of diclofenac intended for use in humans are still widely available and illegally used to treat livestock, the carcasses of which are the main food source for vultures in South Asia.
 
It was announced in March that veterinary diclofenac had been authorised for manufacture and use in Italy and Spain and had been distributed to other European countries. Since then, a coalition of organisations including the Vulture Conservation Foundation, the RSPB and BirdLife International have been campaigning for this decision to be reversed.

Dr Galligan continued: "In light of recent developments in Europe, our findings take on an even more worrying meaning. All of Europe's charismatic Aquila eagles, like the Spanish imperial eagle and, closer to home, the golden eagle, are opportunistic scavengers and therefore could be at risk of diclofenac poisoning.  As we have seen in South Asia, wherever free-ranging livestock are treated with diclofenac, population declines in vultures and eagles can occur. The European Commission needs to recognise this problem and impose a continent-wide ban on veterinary diclofenac before it can impact on our birds."

Last week, the Veterinary Medicines Directorate (VMD) announced measures against the drug. 

In a statement the VMD said: "The UK's Veterinary Medicines Directorate is taking the issue of diclofenac's risks to vulture populations seriously. As a precautionary measure the VMD will not approve any requests from vets to import products containing diclofenac. Furthermore, the VMD has agreed not to issue any export certificates which name diclofenac-containing products in the list of products to be exported."

Sacha Cleminson, Head of International Biodiversity Policy at the RSPB, said: "The announcement from the Veterinary Medicines Directorate is a welcome signal to Europe that the UK is taking the issue seriously. This new evidence underlines the need for a ban across Europe, and ultimately beyond." 

References

1. Diclofenac is toxic to the Steppe Eagle Aquila nipalensis: widening the diversity of raptors threatened by NSAID misuse in South Asia. Anil K. Sharma et al Bird Conservation International Online. 26th May 2014.

2. Have population declines in Egyptian Vulture and Red-headed Vulture in India slowed since the 2006 ban on veterinary diclofenac? Toby H. Galligan et al. Bird Conservation International Online. 1st April 2014.
   

Two enterprising veterinary nurses with a diploma, two certificates and 30 years of experience between them have launched vnpetproducts.co.uk, selling a range of products that they felt were missing from daily practice life.

Surrey-based Sarah Taylor and Zoe Daley launched the website earlier this year with a range which includes the Medicat wrap to make it easier to medicate and examine cats, and the Slumberpet Recovery Coat for dogs and for cats, for maintaining temperature during anaesthetics.

In addition, they've got a range of funky scrub caps, plus ID tags for your scissors and stethoscopes, fob watches, scrub hats and pens.